<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Medexus Pharmaceuticals Inc. — News on 6ix</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc</link>
<description>Latest news and press releases for Medexus Pharmaceuticals Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 15 Apr 2026 21:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/medexus-pharmaceuticals-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835fa8a78dffbe2df13156b.webp</url>
<title>Medexus Pharmaceuticals Inc.</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc</link>
</image>
<item>
<title>Medexus Provides Business Update on GRAFAPEX (treosulfan) for Injection, Capital Allocation, and Investor Conference Participation</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-provides-business-update-on-grafapex-treosulfan-for-injection-capital-allocation-and-investor-conference-participation</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-provides-business-update-on-grafapex-treosulfan-for-injection-capital-allocation-and-investor-conference-participation</guid>
<pubDate>Wed, 15 Apr 2026 21:30:00 GMT</pubDate>
<description>Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 15, 2026) - Medexus Pharmaceutica...</description>
</item>
<item>
<title>Medexus Announces Fiscal Q3 2026 Results, Driven by Continued Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-announces-fiscal-q3-2026-223000848</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-announces-fiscal-q3-2026-223000848</guid>
<pubDate>Wed, 11 Feb 2026 22:30:00 GMT</pubDate>
<description>Management to host conference call at 8:00 AM Eastern time on Thursday, February 12, 2026Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - February 11, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today announced its operating and financial results and provided a business update for the company's third fiscal quarter ended December 31, 2025 (the company's fiscal Q3 2026). All dollar amounts in this press release are in US dollars unless specified otherwise.Key update on...</description>
</item>
<item>
<title>Medexus Schedules Third Fiscal Quarter 2026 Conference Call</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-schedules-third-fiscal-quarter-223000782</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-schedules-third-fiscal-quarter-223000782</guid>
<pubDate>Tue, 03 Feb 2026 22:30:00 GMT</pubDate>
<description>Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - February 3, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday, February 12, 2026 to discuss Medexus's results for its third fiscal quarter ended December 31, 2025. Medexus expects to file its financial statements and MD&A after markets close on February 11, 2026.To participate in the call, please dial the following numbers:877-545-0523 (toll-free) for Canadian and</description>
</item>
<item>
<title>Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Common Shares</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-announces-normal-course-issuer-bid-or-ncib-for-its-common-shares</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-announces-normal-course-issuer-bid-or-ncib-for-its-common-shares</guid>
<pubDate>Thu, 20 Nov 2025 12:30:00 GMT</pubDate>
<description>Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 20, 2025) - Medexus Pharmaceut...</description>
</item>
<item>
<title>Medexus Announces US$51.0 million in New Credit Facilities and Intention to Commence Normal Course Issuer Bid, or NCIB, for its Common Shares</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-announces-usdollar510-million-in-new-credit-facilities-and-intention-to-commence-normal-course-issuer-bid-or-ncib-for-its-common-shares</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-announces-usdollar510-million-in-new-credit-facilities-and-intention-to-commence-normal-course-issuer-bid-or-ncib-for-its-common-shares</guid>
<pubDate>Mon, 17 Nov 2025 13:30:00 GMT</pubDate>
<description>Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 17, 2025) - Medexus Pharmaceut...</description>
</item>
<item>
<title>Medexus Announces Fiscal Q2 2026 Results, Driven by Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-announces-fiscal-q2-2026-results-driven-by-strong-year-to-date-product-level-performance-of-grafapex-treosulfan-for-injection</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-announces-fiscal-q2-2026-results-driven-by-strong-year-to-date-product-level-performance-of-grafapex-treosulfan-for-injection</guid>
<pubDate>Wed, 12 Nov 2025 23:06:00 GMT</pubDate>
<description>Management to host conference call at 8:00 AM Eastern time on Thursday, November 13, 2025 Toront...</description>
</item>
<item>
<title>Medexus Schedules Second Fiscal Quarter 2026 Conference Call</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-schedules-second-fiscal-quarter-2026-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-schedules-second-fiscal-quarter-2026-conference-call</guid>
<pubDate>Tue, 04 Nov 2025 22:30:00 GMT</pubDate>
<description>Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 4, 2025) - Medexus Pharmaceuti...</description>
</item>
<item>
<title>Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-holds-annual-meeting-of-shareholders-and-announces-election-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-holds-annual-meeting-of-shareholders-and-announces-election-of-directors</guid>
<pubDate>Thu, 25 Sep 2025 21:30:00 GMT</pubDate>
<description>Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - September 25, 2025) - Medexus Pharmaceu...</description>
</item>
<item>
<title>Medexus Announces Fiscal Q1 2026 Results, Including Positive Results from US Launch of GRAFAPEX (treosulfan) for Injection</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-announces-fiscal-q1-2026-results-including-positive-results-from-us-launch-of-grafapex-treosulfan-for-injection</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-announces-fiscal-q1-2026-results-including-positive-results-from-us-launch-of-grafapex-treosulfan-for-injection</guid>
<pubDate>Tue, 12 Aug 2025 21:30:00 GMT</pubDate>
<description>Fiscal Q1 2026 net revenue of $24.6 million, net income of $0.5 million, operating income of $0.9...</description>
</item>
<item>
<title>Medexus Schedules First Fiscal Quarter 2026 Conference Call</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-schedules-first-fiscal-quarter-2026-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-schedules-first-fiscal-quarter-2026-conference-call</guid>
<pubDate>Tue, 05 Aug 2025 21:30:00 GMT</pubDate>
<description>Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - August 5, 2025) - Medexus Pharmaceutica...</description>
</item>
<item>
<title>GRAFAPEX (treosulfan) for Injection Receives CMS Approval of New Technology Add-On Payment (NTAP) for Eligible Cases in CMS's Fiscal Year 2026</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/grafapex-treosulfan-for-injection-receives-cms-approval-of-new-technology-add-on-payment-ntap-for-eligible-cases-in-cmss-fiscal-year-2026</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/grafapex-treosulfan-for-injection-receives-cms-approval-of-new-technology-add-on-payment-ntap-for-eligible-cases-in-cmss-fiscal-year-2026</guid>
<pubDate>Tue, 05 Aug 2025 11:00:00 GMT</pubDate>
<description>Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - August 5, 2025) - Medexus Pharmaceutica...</description>
</item>
<item>
<title>Medexus Announces Strong Fiscal Year 2025 Results, Including Initial Results from Launch of GRAFAPEX (treosulfan) for Injection in the United States</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-announces-strong-fiscal-year-2025-results-including-initial-results-from-launch-of-grafapex-treosulfan-for-injection-in-the-united-states</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-announces-strong-fiscal-year-2025-results-including-initial-results-from-launch-of-grafapex-treosulfan-for-injection-in-the-united-states</guid>
<pubDate>Wed, 25 Jun 2025 22:15:00 GMT</pubDate>
<description>Fiscal year 2025 revenue of $108.3 million, record net income of $2.2 million, operating income o...</description>
</item>
<item>
<title>Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2025 Conference Call</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-schedules-fourth-fiscal-quarter-and-fiscal-year-2025-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-schedules-fourth-fiscal-quarter-and-fiscal-year-2025-conference-call</guid>
<pubDate>Tue, 17 Jun 2025 21:00:00 GMT</pubDate>
<description>Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 17, 2025) - Medexus Pharmaceutical...</description>
</item>
<item>
<title>Medexus Successfully Completes Agreement for Public Reimbursement of Trecondyv (treosulfan for injection) in Quebec, Canada</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-successfully-completes-agreement-for-public-reimbursement-of-trecondyv-treosulfan-for-injection-in-quebec-canada</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-successfully-completes-agreement-for-public-reimbursement-of-trecondyv-treosulfan-for-injection-in-quebec-canada</guid>
<pubDate>Thu, 17 Apr 2025 11:00:00 GMT</pubDate>
<description>Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 17, 2025) - Medexus Pharmaceutica...</description>
</item>
<item>
<title>Medexus Provides Update on Progress of Commercialization of GRAFAPEX (treosulfan) for Injection</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-provides-update-on-progress-of-commercialization-of-grafapex-treosulfan-for-injection</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-provides-update-on-progress-of-commercialization-of-grafapex-treosulfan-for-injection</guid>
<pubDate>Mon, 07 Apr 2025 11:00:00 GMT</pubDate>
<description>Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 7, 2025) - Medexus Pharmaceutical...</description>
</item>
<item>
<title>Medexus Completes Agreement to Return US Commercialization Rights for Gleolan to NX Development Corp.</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-completes-agreement-to-return-us-commercialization-rights-for-gleolan-to-nx-development-corp</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-completes-agreement-to-return-us-commercialization-rights-for-gleolan-to-nx-development-corp</guid>
<pubDate>Fri, 14 Mar 2025 11:00:00 GMT</pubDate>
<description>Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - March 14, 2025) - Medexus Pharmaceutica...</description>
</item>
<item>
<title>Medexus Announces Commercial Availability of GRAFAPEX (treosulfan) for Injection</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-announces-commercial-availability-of-grafapex-treosulfan-for-injection</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-announces-commercial-availability-of-grafapex-treosulfan-for-injection</guid>
<pubDate>Mon, 24 Feb 2025 12:00:00 GMT</pubDate>
<description>Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - February 24, 2025) - Medexus Pharmaceut...</description>
</item>
<item>
<title>Canadian Investment Regulatory Organization Trade Resumption - MDP</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/canadian-investment-regulatory-organization-trade-resumption-mdp</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/canadian-investment-regulatory-organization-trade-resumption-mdp</guid>
<pubDate>Thu, 06 Feb 2025 15:51:00 GMT</pubDate>
<description>Canadian Investment Regulatory Organization Trade Resumption - MDP Canada NewsWire ...</description>
</item>
<item>
<title>Canadian Investment Regulatory Organization Trading Halt - MDP</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/canadian-investment-regulatory-organization-trading-halt-mdp</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/canadian-investment-regulatory-organization-trading-halt-mdp</guid>
<pubDate>Thu, 06 Feb 2025 15:45:00 GMT</pubDate>
<description>Canadian Investment Regulatory Organization Trading Halt - MDP Canada NewsWire ...</description>
</item>
<item>
<title>Medexus Announces Strong Fiscal Q3 2025 Results, Well-Positioned to Launch GRAFAPEX (treosulfan) for Injection in the United States</title>
<link>https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-announces-strong-fiscal-q3-2025-results-well-positioned-to-launch-grafapex-treosulfan-for-injection-in-the-united-states</link>
<guid isPermaLink="true">https://6ix.com/company/medexus-pharmaceuticals-inc/news/medexus-announces-strong-fiscal-q3-2025-results-well-positioned-to-launch-grafapex-treosulfan-for-injection-in-the-united-states</guid>
<pubDate>Wed, 05 Feb 2025 22:30:00 GMT</pubDate>
<description>Fiscal Q3 2025 revenue of $30.0 million, net income of $0.7 million, operating income of $3.8 mil...</description>
</item>
</channel>
</rss>